ExpandIschemic Stroke More Common in AFib Patients with OSA, but CHA₂DS₂-VASc Score Adequately Captures Risk
Atrial fibrillation (AFib) patients with obstructive sleep apnea (OSA) have a higher rate of ischemic stroke compared to those without OSA.
ExpandAtrial fibrillation (AFib) patients with obstructive sleep apnea (OSA) have a higher rate of ischemic stroke compared to those without OSA.
ExpandChildren aged 6 to 17 prescribed montelukast were slightly more likely to be diagnosed with suicidal ideation, depression, agitation, or aggression compared to those prescribed inhaled corticosteroids. However, that increase was not statistically significant.
ExpandPrimary lung cancer is more than twice as prevalent in women previously diagnosed with breast cancer compared to women who have not had breast cancer.
ExpandNon-Hispanic Black patients are 32% more likely to have occult hypoxemia, which is an overestimation of a patient’s blood gas by a pulse oximeter that can lead to delayed recognition of low oxygen levels than non-Hispanic White patients.
ExpandAfter one year of treatment, patients on any dosage of tirzepatide or injectable semaglutide experienced greater median weight loss than those on any dosage of liraglutide, dulaglutide, or oral semaglutide.
ExpandFentanyl toxicology testing in overdose ED encounters has more than tripled for most age groups since 2021. Patients aged 13 to 17 experienced the greatest increase in testing rates, going from 5% of encounters to 26% of encounters.
ExpandChildren born to mothers who were obese or overweight before pregnancy and who maintain that BMI category after pregnancy have a significantly higher likelihood of being obese compared with children born to mothers who were not overweight both before and after pregnancy.
ExpandDespite a small decrease in late 2017, parenteral opioid administrations – those given by IV or injection – have risen from 23.3% of pain-related ED encounters in January 2014 to 26.4% of such encounters in December 2023.
ExpandDiabetic patients prescribed tirzepatide, semaglutide, dulaglutide, and exenatide are less likely to be diagnosed with depression after starting the medication compared to those not on a glucagon-like peptide-1 receptor agonist (GLP-1) medication.
ExpandTestosterone replacement therapy (TRT) use is not correlated with an increased rate of testicular cancer.
ExpandIn patients with a higher level of acuity in the emergency department, the presence of outside records is correlated with a 34-63% reduced risk of a code blue event depending on the patient’s age.
ExpandChildren whose mothers were prescribed systemic antifungals in the year after birth are 16% more likely to develop a food allergy compared to those whose mothers were not prescribed an antifungal in the year after birth.
ExpandMore than half of patients are able to maintain weight loss achieved while on semaglutide or liraglutide even a year after discontinuing the medication.
ExpandMen with low testosterone on testosterone replacement therapy (TRT) have a 7.9% increased risk of cardiovascular disease (CVD) compared to those not on TRT.
ExpandThe rate of follow-up after an office visit or telehealth visit in the 7, 30, or 90 days after the initial encounter has stayed fairly consistent over the last three years.
ExpandWomen screened for breast cancer annually have a 17% lower risk of all-cause mortality after a breast cancer diagnosis compared with those screened every two years.
ExpandUric acid levels below 3.5 mg/dL are correlated with increased rates of being diagnosed with non-vascular and vascular dementia, as well as other degenerative neurologic conditions.
ExpandMedicare Advantage patients have higher screening rates for breast cancer and colorectal cancer than traditional Medicare patients.
ExpandPatients with a high free T4 level are more than twice as likely to be diagnosed with takotsubo cardiomyopathy than those with a T4 level on the low end of normal.
ExpandBabies born to mothers with opioid use disorder (OUD) who are prescribed buprenorphine and buprenorphine/naloxone combination medications in the first trimester of pregnancy have a reduced risk of premature birth, low birth weight, and NICU admission when compared to babies born to mothers who are not prescribed medication for OUD.